Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 3
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Jun 4, 2021
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different types of exercise training can affect blood vessel health in people with mental health conditions, specifically those experiencing posttraumatic stress disorder (PTSD) or generalized anxiety disorder (GAD). The researchers want to see if exercise can help improve blood flow and overall vascular function in both healthy individuals and those with these mental health challenges.
To participate, individuals aged 65-74 who are generally healthy and free from serious heart, lung, or metabolic diseases can apply. Those with PTSD need a specific score on a questionnaire designed to measure their symptoms, while individuals with GAD must meet certain criteria related to their anxiety levels. Participants will not be eligible if they are on certain medications, are current smokers, or have other specific health issues. If selected, participants can expect to engage in various exercise programs and contribute to important research that could help improve health outcomes for people with mental health disorders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • apparently healthy and free of overt cardiovascular, pulmonary, or metabolic disease
- • for PTSD group, a score of ≥ 33 on PCL-5 checklist
- • for GAD group, a score of ≥ 10 on the GAD-7 self-report scale and \< 33 on the PCL-5 checklist
- • for Healthy Control group, a score of ≤ 10 on the GAD-7 self-report scale and \< 33 on the PCL-5 checklist
- Exclusion Criteria:
- • taking medications that could influence cardiovascular function
- • current smokers who have recently quit smoking
- • illicit drug use or excessive alcohol consumption
- • pregnant women
- • significant calorie restriction or vitamin/mineral deficiencies
- • limited English proficiency
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, Virginia, United States
Patients applied
Trial Officials
Ryan Garten, PhD
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials